Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
|
By LabMedica International staff writers Posted on 28 Jul 2015 |
In an oral poster presentation of the “Endocrinology in Preventive and Chronic Care” session at AACC 2015 (July 26-30; Atlanta, GA, USA), researchers presented and discussed results of a study suggesting that simple, noninvasive testing of hair samples may offer new insights into the relationship between asthma, levels of the stress-hormone cortisol, and related complications in pregnancy.
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Latest AACC 2015 News
- Automated Molecular Diagnostics System Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
Dementia affects more than 57 million people worldwide and is projected to nearly double within two decades, straining health systems and families. While biomarkers now enable accurate identification of... Read more
Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
High blood pressure during pregnancy is common and can progress to pre-eclampsia, making close monitoring at antenatal visits essential. However, most risk assessment begins only after pregnancy has started.... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring
Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response
Immunotherapy has transformed cancer care, yet durable benefit remains limited to a subset of patients, and clinicians still lack reliable tools to predict response before treatment begins.... Read more
Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing
Respiratory infections drive heavy testing volumes in clinical laboratories, where accurate, timely results across multiple pathogens are essential. Many labs are seeking to streamline workflows and increase... Read moreHematology
view channel
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read more
Blood Test Enables Early Detection of Multiple Myeloma Relapse
Bone marrow biopsies remain central to diagnosing and monitoring multiple myeloma, yet the procedure is painful, invasive, and often repeated over time. Older patients—who represent most new cases—can... Read moreImmunology
view channel
Point-of-Care Tests Could Expand Access to Mpox Diagnosis
Mpox outbreaks in non-endemic regions have underscored the need for rapid, accessible diagnostics to limit transmission. Polymerase chain reaction (PCR) remains the clinical reference, yet it depends on... Read more
T-Cell Senescence Profiling May Predict CAR T Responses
Chimeric antigen receptor (CAR) T-cell therapy can deliver striking, durable remissions, yet many patients experience minimal or no benefit. The quality of patient-derived cytotoxic T lymphocytes used... Read moreMicrobiology
view channel
Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
Tuberculosis remains a major global health challenge and continues to drive significant morbidity and mortality. The World Health Organization’s 2024 global report cites it as the leading cause of death... Read more
Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
Early detection of gastric cancer could be advanced by scalable screening strategies using minimally invasive sampling. Saliva collection is noninvasive and cost-effective, supporting wider adoption... Read morePathology
view channel
FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification
Risk assessment at diagnosis is central to guiding therapy for early-stage, hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) invasive breast cancer, where overtreatment... Read more
New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides
Pathologists worldwide rely on hematoxylin and eosin (H&E) slides to examine tissue architecture, yet these stains do not reveal the underlying molecular activity that often drives disease.... Read moreTechnology
view channel
Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
Pancreatic cancer remains one of the hardest malignancies to treat because tumors are embedded within a dense microenvironment that shapes growth and therapy response. Standard laboratory models often... Read more
New Platform Captures Extracellular Vesicles for Early Cancer Detection
Early diagnosis remains the most effective way to reduce cancer mortality, yet many screening tools miss disease at its earliest stages. Biomarkers shed by tumors into blood and other fluids can be scarce... Read moreIndustry
view channel
Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
Roche has entered into a definitive merger agreement to acquire PathAI, a company focused on digital pathology and artificial intelligence for pathology laboratories and the biopharma industry.... Read more









